{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:06:44Z","timestamp":1790845604359,"version":"4.1.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,19]]},"DOI":"10.1093\/jpids\/pix083","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T11:08:15Z","timestamp":1507547295000},"page":"71-77","source":"Crossref","is-referenced-by-count":31,"title":["Macrolides in Children With Community-Acquired Pneumonia: Panacea or Placebo?"],"prefix":"10.1093","volume":"7","author":[{"given":"Christopher C","family":"Blyth","sequence":"first","affiliation":[{"name":"School of Medicine, University of Western Australia, Crawley"},{"name":"Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S","family":"Gerber","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"key":"key\n\t\t\t\t20180219051128_CIT0001","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archpediatrics.2012.1266","article-title":"Prioritization of comparative effectiveness research topics in hospital pediatrics","volume":"166","author":"Keren","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0002","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180219051128_CIT0003","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011","volume":"66","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20180219051128_CIT0004","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/thoraxjnl-2012-203026","article-title":"British Thoracic Society Paediatric Pneumonia Audit: a review of 3 years of data","volume":"68","author":"Bowen","year":"2013","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20180219051128_CIT0005","doi-asserted-by":"crossref","first-page":"e20162331","DOI":"10.1542\/peds.2016-2331","article-title":"Variability in antibiotic prescribing for community-acquired pneumonia","volume":"139","author":"Handy","year":"2017","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180219051128_CIT0006","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0007","doi-asserted-by":"crossref","first-page":"e1001444","DOI":"10.1371\/journal.pmed.1001444","article-title":"Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study","volume":"10","author":"Spuesens","year":"2013","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0008","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0009","first-page":"CD009175","article-title":"Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia","volume":"10","author":"Wang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180219051128_CIT0010","doi-asserted-by":"crossref","DOI":"10.1201\/b13787","volume-title":"Kucers\u2019 The Use of Antibiotics","author":"Grayson","year":"2010"},{"key":"key\n\t\t\t\t20180219051128_CIT0011","article-title":"From erythromycin to azithromycin and new potential ribosome-binding antimicrobials","volume":"5","author":"Jelic","year":"2016","journal-title":"Antibiotics (Basel)"},{"key":"key\n\t\t\t\t20180219051128_CIT0012","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jac\/dks457","article-title":"Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection","volume":"68","author":"Principi","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180219051128_CIT0013","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jinf.2014.07.017","article-title":"Mycoplasma pneumoniae infections\u2014does treatment help","volume":"69","author":"Spuesens","year":"2014","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180219051128_CIT0014","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-0029-1202939","article-title":"Streptococcus pneumoniae: does antimicrobial resistance matter","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/INF.0000000000001477","article-title":"Ceftaroline activity tested against bacterial isolates causing community-acquired respiratory tract infections and skin and skin structure infections in pediatric patients from United States hospitals: 2012\u20132014","volume":"36","author":"Pfaller","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180219051128_CIT0016","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/INF.0b013e318247f3e0","article-title":"Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States","volume":"31","author":"Yamada","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180219051128_CIT0017","doi-asserted-by":"crossref","first-page":"30078","DOI":"10.2807\/1560-7917.ES.2015.20.48.30078","article-title":"Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015","volume":"20","author":"Brown","year":"2015","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20180219051128_CIT0018","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/324527","article-title":"Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia","volume":"34","author":"Lynch III","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180219051128_CIT0019","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1148\/radiology.189.2.8210390","article-title":"Diffuse panbronchiolitis: follow-up CT examination","volume":"189","author":"Akira","year":"1993","journal-title":"Radiology"},{"key":"key\n\t\t\t\t20180219051128_CIT0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1843.2006.00845.x","article-title":"Diffuse panbronchiolitis in east Asia","volume":"11","author":"Azuma","year":"2006","journal-title":"Respirology"},{"key":"key\n\t\t\t\t20180219051128_CIT0021","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0022","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0954-6111(03)00042-8","article-title":"Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis","volume":"97","author":"Kadota","year":"2003","journal-title":"Respir Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0023","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2169\/internalmedicine.50.4727","article-title":"Effect of azithromycin on patients with diffuse panbronchiolitis: retrospective study of 51 cases","volume":"50","author":"Li","year":"2011","journal-title":"Intern Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0024","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.99.13613809","article-title":"Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection","volume":"13","author":"Nakamura","year":"1999","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180219051128_CIT0025","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180219051128_CIT0026","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180219051128_CIT0027","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1183\/09031936.00068310","article-title":"A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation","volume":"37","author":"Vos","year":"2011","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180219051128_CIT0028","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0029","first-page":"CD002997","article-title":"Macrolides for chronic asthma","volume":"9","author":"Kew","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180219051128_CIT0030","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa044080","article-title":"The effect of telithromycin in acute exacerbations of asthma","volume":"354","author":"Johnston","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0031","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(15)00500-7","article-title":"Azithromycin for episodes with asthma-like symptoms in young children aged 1\u20133 years: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Stokholm","year":"2016","journal-title":"Lancet Respir Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0032","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1365-2222.2012.03979.x","article-title":"Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments","volume":"42","author":"Cameron","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"key\n\t\t\t\t20180219051128_CIT0033","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180219051128_CIT0034","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2009.05.003","article-title":"Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells","volume":"83","author":"Asada","year":"2009","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20180219051128_CIT0035","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1164\/ajrccm.165.8.2103094","article-title":"Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells","volume":"165","author":"Suzuki","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0036","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1248\/bpb.31.217","article-title":"Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells","volume":"31","author":"Miyamoto","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"key\n\t\t\t\t20180219051128_CIT0037","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000239440","article-title":"The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro","volume":"42","author":"Ichimiya","year":"1996","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20180219051128_CIT0038","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jac\/31.5.681","article-title":"Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics","volume":"31","author":"Molinari","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180219051128_CIT0039","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180219051128_CIT0040","first-page":"CD004418","article-title":"Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults","volume":"9","author":"Eliakim-Raz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180219051128_CIT0041","first-page":"CD001954","article-title":"Azithromycin for acute lower respiratory tract infections","volume":"3","author":"Laopaiboon","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180219051128_CIT0042","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/cis414","article-title":"Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"55","author":"Asadi","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180219051128_CIT0043","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jac\/dku033","article-title":"\u03b2-Lactam\/macrolide dual therapy versus \u03b2-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis","volume":"69","author":"Nie","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180219051128_CIT0044","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10180","article-title":"Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children","volume":"35","author":"Kogan","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"key\n\t\t\t\t20180219051128_CIT0045","first-page":"CD004875","article-title":"Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children","volume":"1","author":"Gardiner","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180219051128_CIT0046","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1086\/319981","article-title":"Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections","volume":"32","author":"Principi","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180219051128_CIT0047","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jhm.1904","article-title":"Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia","volume":"7","author":"Shah","year":"2012","journal-title":"J Hosp Med"},{"key":"key\n\t\t\t\t20180219051128_CIT0048","first-page":"307","article-title":"Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children: a 2-year experience","volume":"41","author":"Lu","year":"2008","journal-title":"J Microbiol Immunol Infect"},{"key":"key\n\t\t\t\t20180219051128_CIT0049","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/AAC.02039-13","article-title":"Antibiotic utilization for acute respiratory tract infections in U.S. emergency departments","volume":"58","author":"Donnelly","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180219051128_CIT0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jpeds.2014.04.062","article-title":"Variation in resource utilization for the management of uncomplicated community-acquired pneumonia across community and children\u2019s hospitals","volume":"165","author":"Leyenaar","year":"2014","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20180219051128_CIT0051","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1542\/peds.2014-3047","article-title":"Antibiotic choice for children hospitalized with pneumonia and adherence to national guidelines","volume":"136","author":"Williams","year":"2015","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180219051128_CIT0052","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1086\/591410","article-title":"Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia","volume":"47","author":"Bradley","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180219051128_CIT0053","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00006454-199810000-00004","article-title":"Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children","volume":"17","author":"Harris","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180219051128_CIT0054","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00006454-199902000-00004","article-title":"Etiology and treatment of community-acquired pneumonia in ambulatory children","volume":"18","author":"Wubbel","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180219051128_CIT0055","first-page":"704","article-title":"Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community-acquired pneumonia in children","volume":"13","author":"Aurangzeb","year":"2003","journal-title":"J Coll Physicians Surg Pak"},{"key":"key\n\t\t\t\t20180219051128_CIT0056","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/INF.0000000000000740","article-title":"Comparative effectiveness of beta-lactam versus macrolide monotherapy in children with pneumonia diagnosed in the outpatient setting","volume":"34","author":"Ambroggio","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180219051128_CIT0057","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jpeds.2012.06.067","article-title":"Comparative effectiveness of empiric \u03b2-lactam monotherapy and \u03b2-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia","volume":"161","author":"Ambroggio","year":"2012","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20180219051128_CIT0058","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ppul.23312","article-title":"Beta-lactam versus beta- lactam\/macrolide therapy in pediatric outpatient pneumonia","volume":"51","author":"Ambroggio","year":"2016","journal-title":"Pediatr Pulmonol"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/7\/1\/71\/24012312\/pix083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T03:32:59Z","timestamp":1659583979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/7\/1\/71\/4583480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,10,31]]},"published-print":{"date-parts":[[2018,2,19]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/pix083","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,10,31]]}}}